Novo Nordisk Investigational Site — Boston, Massachusetts

Novo Nordisk Investigational Site is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Novo Nordisk Investigational Site has participated in 37 clinical trials.

Therapeutic areas: Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors.

Sponsors: Novo Nordisk A/S.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novo Nordisk Investigational Site?

Novo Nordisk Investigational Site has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novo Nordisk Investigational Site conducted?

Novo Nordisk Investigational Site has 37 clinical trials on record. Their work covers Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors.

Is Novo Nordisk Investigational Site accredited by Crixeo Health?

Yes — Novo Nordisk Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Novo Nordisk Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.